Peruvian President Martin Vizcarra on Friday visited Cayetano Heredia University's Research Center to verify Phase 3 clinical trials of the COVID-19 vaccine candidate developed by Chinese laboratory Sinopharm.
The Head of State met with the Chinese delegation and Dr. German Malaga, who is the principal investigator of the vaccine study at the above-mentioned academic institution.
(END) RMCH/RMB/MVB
Published: 9/11/2020